COVID-19 vaccination and race - A nationwide survey of vaccination status, intentions, and trust in the US general population

• Published in: Journal of managed care & specialty pharmacy Vol. 28; no. 12; pp. 1429 - 1438
• Main Authors: Brown, Carolyn, Morlock, Amy, Blakolmer, Karin, Heidari, Elham, Morlock, Robert
• Format: Journal Article
• Language: English
• Published: United States Academy of Managed Care Pharmacy 01-12-2022
• Subjects: Adult; Child; COVID-19 - prevention & control; COVID-19 Vaccines - therapeutic use; Cross-Sectional Studies; Humans; Intention; Surveys and Questionnaires; Trust; Vaccination
• ISSN: 2376-0540; 2376-1032
• DOI: 10.18553/jmcp.2022.28.12.1429

COVID-19 vaccine hesitancy for adults and children varies depending on societal factors, race, and trust ascribed to the source of vaccine information.
To assess COVID-19 vaccination rates and trust levels for vaccine information by race at 2 time points.
Online cross-sectional data from US adults were collected in February/March 2021 (T1) and November 2021 (T2). Questions included vaccination status, reasons for vaccine refusal, trust levels for vaccine information and the Wake Forest Physician Trust Scale. At T2, parents were asked about vaccination status of children aged 12-18 years and intent for children aged 5-11 years. Vaccination rates and trust levels for vaccine information were measured. Multivariable logistic regression was used to identify characteristics predictive of receiving COVID-19 vaccination.
Vaccination rates were 20.2% and 70.8% at T1 and T2, respectively. At T1 and T2, higher proportions of White (23.2% and 72.0%) and Other race (14.4% and 75.2%) respondents were vaccinated relative to Black respondents (9.6% and 64.4%) (
< 0.05). In descending order, respondents' doctors, family members, and pharmacists were the most trusted information sources. Black parents, relative to White and Other parents with unvaccinated children aged 12-18 years or who were not very likely to vaccinate younger children, reported lowest physician trust (
< 0.01). At T1, being married, college educated, and older and having greater Wake Forest Physician Trust Scale scores and a higher number of comorbidities predicted a higher likelihood of being vaccinated. Being Black, having a median household income less than $100,000, and residing in the Northeast or Midwest, relative to the West, predicted a decreased likelihood of being vaccinated. At T2, race and comorbidities were no longer predictive of vaccination.
Racial variation in vaccination status decreased from T1 to T2. Physician trust predicted vaccination status and intent regardless of race. Respondents' doctors, family members, and pharmacists are trusted sources of vaccine information, and targeting these influencers may reduce vaccination hesitancy.
Dr Brown reports personal fees from Taiho Oncology, outside the submitted work. Dr Morlock reports personal fees from Johnson and Johnson, Heron Therapeutics, Evofem Biosciences, Horizon Therapeutics, and Taiho Oncology, outside the submitted work. Amy Morlock reports personal fees from both AbbVie (formerly Allergan) and Ironwood, outside the submitted work. Drs Blakolmer and Heidari have nothing to disclose.